Prognostic value of total metabolic tumour volume and therapy-response assessment by [18F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors
Alessio Annovazzi, Virginia Ferraresi, Sandra Rea, Michelangelo Russillo, Davide Renna, Silvia Carpano, Rosa Sciuto
Topics & Concepts
MedicineInternal medicineOncologyMelanomaProportional hazards modelHazard ratioProgression-free survivalProgressive diseaseMultivariate analysisOverall survivalChemotherapyCancer researchConfidence intervalMelanoma and MAPK PathwaysCutaneous Melanoma Detection and ManagementBrain Metastases and Treatment